Authors: Laban, U Kurrasch-Orbaugh, D Marona-Lewicka, D Nichols, DE

Citation: U. Laban et al., A novel fluorinated tryptamine with highly potent serotonin 5-HT1A receptor agonist properties, BIOORG MED, 11(6), 2001, pp. 793-795

Authors: Blair, JB Kurrasch-Orbaugh, D Marona-Lewicka, D Cumbay, MG Watts, VJ Barker, EL Nichols, DE

Citation: Jb. Blair et al., Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines, J MED CHEM, 43(24), 2000, pp. 4701-4710

Authors: Blair, JB Marona-Lewicka, D Kanthasamy, A Lucaites, VL Nelson, DL Nichols, DE

Citation: Jb. Blair et al., Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine, J MED CHEM, 42(6), 1999, pp. 1106-1111

Authors: Gerasimov, M Marona-Lewicka, D Kurrasch-Orbaugh, DM Qandil, AM Nichols, DE

Citation: M. Gerasimov et al., Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain, J MED CHEM, 42(20), 1999, pp. 4257-4263

Authors: Parker, MA Marona-Lewicka, D Lucaites, VL Nelson, DL Nichols, DE

Citation: Ma. Parker et al., A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor, J MED CHEM, 41(26), 1998, pp. 5148-5149